The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...

Health Canada is supposed to issue rulings on new generics – which are copies of branded drugs whose patents have expired – ...

The FDA accepted a resubmitted new drug application for reproxalap, a first-in-class investigational topical therapy for dry ...

Importers can now apply, track, and receive approval for their drug consignments via an integrated digital portal, ...

AbbVie is seeking a new way to fight chronic lymphocytic leukemia by combining its oncology drug Venclexta with another ...

After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...

The new guidelines aim to streamline India’s drug approvals, improve transparency, and align regulatory practices with global ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

Johnson & Johnson (NYSE:JNJ) is one of the best trade‑war resistant stocks to buy now. On July 21, 2025, J&J submitted a New ...

Shares of Zymeworks were higher after the Food and Drug Administration cleared the company's investigational new drug application for its treatment for liver cancer. The stock rose 8.5%, to $14.46, in ...

The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.

Potential NIH and FDA cuts could lower the number of new drugs that come to market in the next three decades, according to a ...